Ozempic’s approval follows Jardiance’s expanded heart indication last July.
Already approved for adult patients, Fiasp is now available for children.
Approval of Ubrelvy follows several new migraine drugs.
The fish oil drug is approved to reduce cardiovascular risk.
This is the agency’s first generic approvals of Gilenya.
Sandoz now has 2 biosimilars to the popular cancer drug.
This is the eighth indication approved for Xarelto.
Drug is the only respiratory therapy that can be given at home every 8 weeks.
How the first oral GLP-1 oral treatment for type 2 diabetes is unique and how it will be priced compared to other GLP-1 medications.
Targeted therapy gives new hope to patients with an aggressive form of lung cancer.